How Your Body Processes a New Tablet Medicine With and Without Food
Treatments studied
This early-stage study tests how a new medicine called sonrotoclax is absorbed and processed by your body when taken as a tablet with and without food. Researchers want to understand the best way to take this medicine to help it work effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in overall good health with no serious medical conditions
- Your body mass index (BMI) must be between 18 and 32
- Your B-cell count (a type of immune cell) must be above 150 cells per microliter
- You cannot have had stomach or bowel surgery that affects how your body absorbs medicine (appendix removal and hernia repair are okay)
- You must not take other medications that interfere with how your body processes drugs for at least 30 days before the study
- You cannot have had a serious infection in the 4 weeks before starting the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.
This study tests how two different tablet versions of the study drug BGB-58067 enter the body and how food affects the drug. Healthy volunteers take the drug to help understand the best way to give it in future trials.
This trial studies how food changes the way your body processes a new medicine called VV119. It helps make sure the drug works safely and effectively. Healthy adults are needed to participate.
This trial tests how a drug called sonrotoclax is processed by the body in people with severe liver impairment compared to people with normal liver function. It aims to check the drug's safety and how it is absorbed, which may help guide dosing for patients with liver issues.
This study tests how a new tablet (called HRS9531) is absorbed and processed by the body under different conditions (like with or without food). It is for healthy volunteers to find the best way to take the tablet.
This study tests a new slow-release tablet (Hemay5259) in healthy people. It aims to check how safe the drug is, how it works in the body, and whether food changes its effects. Participants will receive the drug and be closely monitored for side effects.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.